Unlock stock picks and a broker-level newsfeed that powers Wall Street.
5.33
-0.06
(-1.11%)
At close: April 7 at 4:00:01 PM EDT
5.36
+0.03
+(0.56%)
After hours: April 7 at 7:07:38 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
138,719.35
138,719.35
139,917.22
110,775.61
133,670.45
Cost of Revenue
43,600.03
43,600.03
34,253.03
32,958.20
26,544.07
Gross Profit
95,119.32
95,119.32
105,664.19
77,817.41
107,126.38
Operating Expense
25,136.05
25,136.05
22,043.02
35,117.24
18,033.58
Operating Income
69,983.27
69,983.27
83,621.17
42,700.17
89,092.80
Other Income Expense
6,087.12
6,087.12
4,155.51
1,432.57
218.94
Pretax Income
76,070.39
76,070.39
87,776.67
44,132.73
89,311.74
Tax Provision
16,856.17
16,856.17
19,707.85
10,227.93
19,860.98
Net Income Common Stockholders
59,214.22
59,214.22
68,068.83
33,904.81
69,450.77
Average Dilution Earnings
--
--
--
-400.66
-117.77
Diluted NI Available to Com Stockholders
59,214.22
59,214.22
68,068.83
33,504.14
69,333
Basic EPS
1.20
0.83
0.95
0.46
0.92
Diluted EPS
1.20
0.82
0.95
0.46
0.91
Basic Average Shares
71,165.43
71,253.17
71,362.21
72,929.55
75,322.19
Diluted Average Shares
71,979.23
71,905.71
71,679.27
73,546.50
76,402.72
Total Operating Income as Reported
69,983.27
69,983.27
83,621.17
42,700.17
89,092.80
Total Expenses
68,736.08
68,736.08
56,296.06
68,075.44
44,577.66
Net Income from Continuing & Discontinued Operation
59,214.22
59,214.22
68,068.83
33,904.81
69,450.77
Normalized Income
59,214.22
59,214.22
68,068.83
33,597.10
69,359.14
EBIT
69,983.27
69,983.27
83,621.17
42,700.17
89,092.80
EBITDA
70,521.70
70,521.70
84,159.46
43,217.81
89,615.17
Reconciled Cost of Revenue
43,600.03
43,600.03
34,253.03
32,958.20
26,544.07
Reconciled Depreciation
538.42
538.42
538.29
517.64
522.37
Net Income from Continuing Operation Net Minority Interest
59,214.22
59,214.22
68,068.83
33,904.81
69,450.77
Total Unusual Items Excluding Goodwill
--
--
--
400.66
117.77
Total Unusual Items
--
--
--
400.66
117.77
Normalized EBITDA
70,521.70
70,521.70
84,159.46
42,817.15
89,497.40
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
--
92.95
26.14
12/31/2021 - 9/10/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EBS Emergent BioSolutions Inc.
4.4400
-1.77%
ANIK Anika Therapeutics, Inc.
13.92
-0.64%
COLL Collegium Pharmaceutical, Inc.
27.38
-2.70%
LNTH Lantheus Holdings, Inc.
95.45
+4.98%
ACUR Acura Pharmaceuticals, Inc.
0.0198
+1,000.00%
AMPH Amphastar Pharmaceuticals, Inc.
25.00
-6.05%
IRWD Ironwood Pharmaceuticals, Inc.
1.2700
-5.22%
SNOA Sonoma Pharmaceuticals, Inc.
1.9100
-5.45%
EVOK Evoke Pharma, Inc.
2.3500
+5.86%
ASRT Assertio Holdings, Inc.
0.5884
-6.19%